NovaBridge Biosciences (NBP) Enterprise Value (2018 - 2022)
NovaBridge Biosciences (NBP) has disclosed Enterprise Value for 5 consecutive years, with -$485.0 million as the latest value for Q4 2022.
- Quarterly Enterprise Value rose 27.5% to -$485.0 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$485.0 million through Dec 2022, up 27.5% year-over-year, with the annual reading at -$485.0 million for FY2022, 27.5% up from the prior year.
- Enterprise Value for Q4 2022 was -$485.0 million at NovaBridge Biosciences, up from -$668.9 million in the prior quarter.
- The five-year high for Enterprise Value was -$169.3 million in Q4 2019, with the low at -$722.8 million in Q4 2020.
- Average Enterprise Value over 5 years is -$457.8 million, with a median of -$485.0 million recorded in 2022.
- The sharpest move saw Enterprise Value skyrocketed 30.36% in 2019, then tumbled 326.94% in 2020.
- Over 5 years, Enterprise Value stood at -$243.1 million in 2018, then surged by 30.36% to -$169.3 million in 2019, then crashed by 326.94% to -$722.8 million in 2020, then increased by 7.46% to -$668.9 million in 2021, then rose by 27.5% to -$485.0 million in 2022.
- According to Business Quant data, Enterprise Value over the past three periods came in at -$485.0 million, -$668.9 million, and -$722.8 million for Q4 2022, Q4 2021, and Q4 2020 respectively.